Form 8-K - Current report:
SEC Accession No. 0001628280-16-015094
Filing Date
2016-04-29
Accepted
2016-04-29 17:21:12
Documents
3
Period of Report
2016-04-29
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K - VASCULAN a8k-vasculanprogram.htm 8-K 20716
2 EXHIBIT 99.1 pressreleaseforvasculan-01.htm EX-99.1 18052
3 cumberlandpharmaceuti_image1.jpg GRAPHIC 37721
  Complete submission text file 0001628280-16-015094.txt   91864
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 161608425
SIC: 2834 Pharmaceutical Preparations